Internet-Based Drug Prevention Education for College Students

描述（由申请人提供）：本申请建议为大学生开发和测试一个互动的在线药物使用预防计划，MyStudentBody-Drugs（MSB-Drugs）。面向初级和二级预防，MSB药物将促进动机，以预防开始，或减少，药物使用和相关的危险行为。与酒精相比，预防吸毒在校园里被忽视，尽管吸毒很普遍，后果很严重。海洛因是使用最广泛的非法药物，其次是处方药的非医疗使用，包括兴奋剂（苯丙胺、哌甲酯）和类阿片（羟考酮、氢可酮）。2003年，大约10%的高中毕业生报告非医疗使用氢可酮，使其成为这一群体中第三大滥用药物，仅次于大麻和安非他明。从2002年到2003年，滥用羟考酮在大学年龄段的年轻人中增加了近40%。将处方药与其他药物（如酒精）混合使用，会进一步增加药物相互作用和过量的风险。大学生容易获得和有效的药物预防的公共卫生需求是明确的。国家药物开发署最近的举措认识到了这一需要（《处方药滥用》，PA-01 - 110; Claudow，2005年）。MSB药物将使用技术和丰富的媒体来纳入关键的循证预防功能，包括个人风险评估和量身定制的反馈，以促进动机，有关不同药物和成瘾的相关教育，以促进准确的风险评估，以及技能建设活动，以促进拒绝和应对技能和自我效能。第一阶段涉及概念验证研究，以证明产品的可行性。第二阶段将涉及一个全面运作的MSB药物网站的生产和可用性测试，以及一项随机对照试验，以评估影响药物相关知识、态度和行为的计划效力。

DESCRIPTION (provided by applicant): This application proposes development and testing of an interactive, online drug use prevention program for college students, MyStudentBody-Drugs (MSB-Drugs). Geared toward primary and secondary prevention, MSB-Drugs will promote motivation to prevention initiation of, or reduce, drug use and associated risk behaviors. Compared to alcohol, drug use prevention is neglected on campuses, despite the prevalence of use and significant consequences. Marijuana is the most widely used illicit drug, followed by non-medical use of prescription drugs, including stimulants (dextroamphetamine, methyphenidate) and opioids (oxycodone, hydrocodone). In 2003, roughly 10 percent of high school seniors reported non- medical use of hydrocodone, making it the third most abused substance for this group, after marijuana and amphetamines. From 2002 to 2003, abuse of oxycodone increased by nearly 40 percent among college- aged youth. Mixing prescription drugs with other drugs, such as alcohol, further increases risk for drug interactions and overdose. The public health need for easily accessible and effective drug prevention for college students is clear. Recent NIDA initiatives recognize this need (Prescription Drug Abuse, PA-01-110; Volkow, 2005). MSB-Drugs will use technology and rich media to incorporate key evidence-based prevention features, including personal risk assessments with tailored feedback to promote motivation, relevant education about different drugs and addiction to foster accurate risk appraisals, and skill-building activities to promote refusal and coping skills and self-efficacy. Phase I involved proof of concept research to demonstrate product feasibility. Phase II will involve production and usability testing of a fully operational MSB-Drugs website, and a randomized, controlled trial to assess program efficacy for influencing drug- related knowledge, attitudes, and behaviors.